PCVX

Vaxcyte (PCVX)

About Vaxcyte (PCVX)

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Details

Daily high

$114.61

Daily low

$111.16

Price at open

$111.60

52 Week High

$121.06

52 Week Low

$45.00

Market cap

13.9B

Dividend yield

0.00%

Volume

561,811

Avg. volume

767,956

P/E ratio

-24.06

Vaxcyte News